Commissioner of Central Excise Hyderabad v. M/S Sarvotham Care Limited
In short. The case revolves around the classification of 'Ketoconazole Shampoo' and 'Nizral Shampoo' for central excise duty purposes. The respondent, M/s Sarvotham Care Limited, contended that these products should be classified under CSH 3003.10 as medicinal products, which attract a lower excise duty of 16%. Conversely, the appellant, the Commissioner of Central Excise, argued for classification under CSH 3305.99 as cosmetic preparations, which incur a higher duty of 24%. The Supreme Court ultimately upheld the Tribunal's decision that the products are medicinal, thus supporting the respondent's classification.
Facts
The respondent manufactures 'Ketoconazole Shampoo' and 'Nizral Shampoo', which are sold in 50 ml and 5 ml bottles. The dispute arose when the respondent classified these products under CSH 3003.10 of the Central Excise Tariff Act, 1985, asserting they are medicinal. The Revenue disagreed, classifying them under CSH 3305.99 as hair preparations. Following a show cause notice demanding differential duty of Rs. 8,12,194, the Adjudicating Authority confirmed this demand. The respondent's appeal to the Commissioner (Appeals) was dismissed, but the CESTAT ruled in favor of the respondent, leading to the current appeal by the Revenue.
Arguments
Petitioner Arguments
The petitioner (appellant) argued that the products in question are merely cosmetic preparations intended for hair care, thus falling under the higher excise duty category. They emphasized that the products do not meet the criteria for medicinal classification as defined in the relevant tariff entries. The court addressed these arguments by examining the evidence presented, ultimately finding that the products had medicinal uses and were sold under prescriptions, which supported the respondent's classification.
Respondent Arguments
The respondent contended that the shampoos are indeed medicinal products used for treating various skin conditions and are sold in pharmacies under medical prescriptions. They provided substantial evidence, including sales data and expert testimonies, to support their claim. The court found this evidence compelling, leading to the conclusion that the products should be classified as pharmaceuticals rather than cosmetics.
Precedents considered
The judgment referenced previous cases where the classification of products was determined based on their intended use and the evidence of medicinal properties. While specific precedents were not detailed in the provided text, the court's reliance on the CESTAT's findings indicates a precedent of considering the actual use and market perception of products in classification disputes.
Legal principles
The court considered the definitions and classifications under the Central Excise Tariff Act, particularly the distinctions between pharmaceutical products and cosmetic preparations. The key legal principle involved was the interpretation of product classification based on intended use and evidence of medicinal efficacy.
Decision and reasoning
Rationale
The court's rationale centered on the substantial evidence presented by the respondent demonstrating the medicinal use of the shampoos. The court criticized the Revenue's narrow interpretation of the products' use and emphasized the importance of considering the broader context of how these products are marketed and utilized in practice.
Outcome
The Supreme Court upheld the CESTAT's decision, affirming that the 'Ketoconazole Shampoo' and 'Nizral Shampoo' are classified as medicinal products under CSH 3003.10. The court ordered the Revenue to cease the demand for the differential duty of Rs. 8,12,194. Specific instructions regarding the appeal process or conditions for bail were not detailed in the provided text.
Conclusion
This judgment reinforces the principle that product classification for excise duty should consider actual usage and market practices rather than solely the product's appearance or nominal description. It highlights the importance of evidence in classification disputes and sets a precedent for similar cases involving the classification of health-related products.
Read the full judgment on the Supreme Court website (PDF)
Find the judgments that followed or distinguished it, with the paragraph relied on in each. Two answers free on WhatsApp, no signup.